Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1560) 1560
amoxicillin-potassium clavulanate combination - therapeutic use (1128) 1128
female (954) 954
male (948) 948
anti-bacterial agents - therapeutic use (893) 893
adult (543) 543
drug therapy, combination - therapeutic use (527) 527
middle aged (502) 502
amoxicillin - therapeutic use (475) 475
amoxicillin-potassium clavulanate combination (435) 435
index medicus (413) 413
aged (384) 384
clavulanic acids - therapeutic use (381) 381
child (335) 335
treatment outcome (327) 327
infectious diseases (291) 291
adolescent (289) 289
child, preschool (283) 283
acute disease (245) 245
microbiology (239) 239
infant (221) 221
amoxicillin-potassium clavulanate combination - administration & dosage (209) 209
antibiotics (208) 208
pharmacology & pharmacy (205) 205
anti-bacterial agents - administration & dosage (191) 191
prospective studies (181) 181
microbial sensitivity tests (165) 165
amoxicillin (157) 157
amoxicillin-potassium clavulanate combination - adverse effects (157) 157
double-blind method (143) 143
bacterial infections - drug therapy (138) 138
aged, 80 and over (136) 136
administration, oral (134) 134
medicine, general & internal (134) 134
pediatrics (134) 134
animals (130) 130
children (129) 129
otitis media - drug therapy (126) 126
cephalosporins - therapeutic use (123) 123
drug therapy, combination (123) 123
drug therapy, combination - administration & dosage (123) 123
amoxicillin - administration & dosage (114) 114
drug therapy, combination - adverse effects (112) 112
anti-bacterial agents - adverse effects (111) 111
surgery (110) 110
amoxicillin-potassium clavulanate combination - pharmacology (108) 108
anti-bacterial agents - pharmacology (108) 108
infections (104) 104
management (101) 101
clavulanic acids - administration & dosage (99) 99
drug combinations - therapeutic use (99) 99
follow-up studies (99) 99
risk factors (97) 97
respiratory tract infections - drug therapy (95) 95
amoxicillin - adverse effects (94) 94
time factors (94) 94
retrospective studies (91) 91
anti-infective agents - therapeutic use (89) 89
metronidazole - therapeutic use (89) 89
drug administration schedule (88) 88
urinary tract infections - drug therapy (87) 87
health aspects (85) 85
clavulanic acids - adverse effects (80) 80
dentistry, oral surgery & medicine (76) 76
recurrence (76) 76
immunology (75) 75
therapy (75) 75
drug therapy (74) 74
sinusitis - drug therapy (73) 73
tomography, x-ray computed (73) 73
diagnosis (72) 72
infection (71) 71
community-acquired infections - drug therapy (70) 70
ciprofloxacin - therapeutic use (69) 69
diagnosis, differential (69) 69
antibiotic prophylaxis (68) 68
streptococcus pneumoniae - drug effects (68) 68
young adult (68) 68
drug resistance, bacterial (67) 67
clavulanic acid (66) 66
surgical wound infection - prevention & control (66) 66
amoxicillin/clavulanate (62) 62
pneumonia, bacterial - drug therapy (62) 62
cefuroxime - therapeutic use (61) 61
otorhinolaryngology (58) 58
chronic disease (57) 57
efficacy (57) 57
bronchitis - drug therapy (55) 55
care and treatment (55) 55
penicillins - therapeutic use (55) 55
randomized controlled trials as topic (55) 55
resistance (54) 54
combined modality therapy (53) 53
abridged index medicus (52) 52
azithromycin - therapeutic use (52) 52
escherichia coli infections - drug therapy (52) 52
trimethoprim, sulfamethoxazole drug combination - therapeutic use (52) 52
pharmacokinetics (51) 51
gentamicins - therapeutic use (50) 50
pneumonia (50) 50
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1355) 1355
French (103) 103
Spanish (62) 62
Russian (42) 42
German (33) 33
Japanese (17) 17
Dutch (11) 11
Italian (9) 9
Hungarian (5) 5
Polish (5) 5
Czech (4) 4
Turkish (4) 4
Bulgarian (3) 3
Romanian (2) 2
Croatian (1) 1
Danish (1) 1
Finnish (1) 1
Hebrew (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Treating Foot Infections in Diabetic Patients: A Randomized, Multicenter, Open-Label Trial of Linezolid versus Ampicillin-Sulbactam/Amoxicillin-Clavulanate
by Benjamin A. Lipsky and Kamal Itani and Carl Norden and The Linezolid Diabetic Foot Infections Study Group and Linezolid Diabet Foot Infect Study and Linezolid Diabetic Foot Infections Study Group and the Linezolid Diabetic Foot Infections Study Group
Clinical Infectious Diseases, ISSN 1058-4838, 1/2004, Volume 38, Issue 1, pp. 17 - 24
Foot infections in diabetic patients are predominantly caused by gram-positive cocci, many of which are now antibiotic resistant. Because linezolid is active... 
Osteomyelitis | Pathogens | Antibiotics | Diabetes complications | Major Articles | Diabetes mellitus | Diabetic foot | Bones | Infections | Diabetes | Medical cures | INFECTIOUS DISEASES | PENETRATION | MICROBIOLOGY | MELLITUS | IMMUNOLOGY | RESISTANT STAPHYLOCOCCUS-AUREUS | THERAPY | VANCOMYCIN | PERIPHERAL VASCULAR-DISEASE | LOWER-EXTREMITY INFECTIONS | CIPROFLOXACIN | EPIDEMIOLOGY | PNU-100766 | Linezolid | Ampicillin - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Diabetes Complications | Acetamides - therapeutic use | Humans | Sulbactam - therapeutic use | Foot Diseases - complications | Treatment Outcome | Drug Therapy, Combination | Foot Diseases - drug therapy | Oxazolidinones - therapeutic use | Methicillin | Diabetics | Statistics | Foot diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Randomised controlled trial of amoxycillin clavulanate in children with chronic wet cough
by Marchant, Julie and Masters, Ian Brent and Champion, Anita and Petsky, Helen and Chang, Anne B
Thorax, ISSN 0040-6376, 2012, Volume 67, Issue 8, pp. 689 - 693
Background Despite guideline recommendations, there are no published randomised controlled trial data on the efficacy of antibiotics for chronic wet cough in... 
ANTIBIOTICS | BACTERIAL BRONCHITIS | RESPIRATORY SYSTEM | PART | AIRWAY INFLAMMATION | MORAXELLA-CATARRHALIS | YOUNG-CHILDREN | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Cough - drug therapy | Humans | Child, Preschool | Infant | Male | Treatment Outcome | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Bronchitis - drug therapy | Adolescent | Bronchitis - complications | Female | Bronchoalveolar Lavage Fluid - cytology | Cough - microbiology | Child | Chronic Disease | Antibiotics | Usage | Amoxicillin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Are third-generation cephalosporins associated with a better prognosis than amoxicillin–clavulanate in patients hospitalized in the medical ward for community-onset pneumonia?
by Batard, E and Javaudin, F and Kervagoret, E and Caruana, E and Le Bastard, Q and Chapelet, G and Goffinet, N and Montassier, E
Clinical Microbiology and Infection, ISSN 1198-743X, 11/2018, Volume 24, Issue 11, pp. 1171 - 1176
Objectives: We aimed to assess whether treatment with ceftriaxone/cefotaxime is associated with lower in-hospital mortality than amoxicillin–clavulanate in... 
Amoxicillin–clavulanate | Community-onset pneumonia | Ceftriaxone | Cefotaxime | Mortality | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Community-Acquired Infections - drug therapy | Humans | Aged, 80 and over | Female | Male | Pneumonia, Bacterial - drug therapy | Aged | Retrospective Studies | Cephalosporins - classification
Journal Article
Details down arrow
4. Full Text Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: A randomized study of amoxicillin-clavulanate and ceftriaxone
by Rosón, B and Carratalà, J and Tubau, F and Dorca, J and Liñares, J and Pallares, R and Manresa, F and Gudiol, F
Microbial Drug Resistance, ISSN 1076-6294, 2001, Volume 7, Issue 1, pp. 85 - 96
Empirical antibiotic therapy of community-acquired pneumonia (CAP) has been complicated by the worldwide emergence of penicillin resistance among Streptococcus... 
INFECTIOUS DISEASES | RISK-FACTORS | SYSTEMIC INFECTIONS | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | ANTIMICROBIAL RESISTANCE | CHILDREN | DECREASED SUSCEPTIBILITY | FLUOROQUINOLONES | PNEUMOCOCCAL PNEUMONIA | PHARMACOLOGY & PHARMACY | PENICILLIN | SPAIN | Pneumonia, Bacterial - microbiology | Streptococcus pneumoniae - drug effects | beta-Lactam Resistance | Humans | Middle Aged | Male | Drug Therapy, Combination - therapeutic use | Penicillin G - pharmacology | Cephalosporins - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Ceftriaxone - therapeutic use | Community-Acquired Infections - drug therapy | Female | Pneumonia, Bacterial - drug therapy | Aged | Penicillins - pharmacology | Community-Acquired Infections - microbiology | Penicil·lina | Estreptococs | Pneumonia | Pneumònia | Medicaments antibacterians | Drug resistance | Antibacterial agents | Streptococcus | Amoxicil·lina | Resistència als medicaments | Amoxicillin | Penicillin | Pneumococs | Streptococcus pneumonia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Once-Daily, High-Dose Levofloxacin versus Ticarcillin-Clavulanate Alone or Followed by Amoxicillin-Clavulanate for Complicated Skin and Skin-Structure Infections: A Randomized, Open-Label Trial
by Donald R. Graham and David A. Talan and Ronald L. Nichols and Christopher Lucasti and Michael Corrado and Nancy Morgan and Cynthia L. Fowler
Clinical Infectious Diseases, ISSN 1058-4838, 8/2002, Volume 35, Issue 4, pp. 381 - 389
This study tested whether levofloxacin, at a new high dose of 750 mg, was effective for the treatment of complicated skin and skin-structure infections... 
Osteomyelitis | Pathogens | Diabetes complications | Major Articles | Antimicrobials | Ulcers | Aerobic bacteria | Infections | Skin | Diabetes | Dosage | UNCOMPLICATED SKIN | INFECTIOUS DISEASES | HOSPITALIZED-PATIENTS | MULTICENTER | SAFETY | MICROBIOLOGY | PHARMACODYNAMICS | IMMUNOLOGY | PHARMACOKINETICS | DOUBLE-BLIND | 750-MILLIGRAM | HEALTHY-VOLUNTEERS | CIPROFLOXACIN | Levofloxacin | Humans | Middle Aged | Ofloxacin - therapeutic use | Ticarcillin - adverse effects | Male | Drug Therapy, Combination - adverse effects | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Clavulanic Acids - adverse effects | Ofloxacin - adverse effects | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Ofloxacin - administration & dosage | Female | Anti-Infective Agents - adverse effects | Ticarcillin - administration & dosage | Clavulanic Acids - administration & dosage | Anti-Infective Agents - therapeutic use | Clavulanic Acids - therapeutic use | Skin Diseases - drug therapy | Treatment Outcome | Drug Therapy, Combination - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Anti-Infective Agents - administration & dosage | Drug Therapy, Combination - administration & dosage | Ticarcillin - therapeutic use | Infection | Evaluation | Amoxicillin | Ticarcillin | Clavulanate
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections
by Malangoni, Mark A and Song, James and Herrington, Janet and Choudhri, Shurjeel and Pertel, Peter
Annals of Surgery, ISSN 0003-4932, 08/2006, Volume 244, Issue 2, pp. 204 - 211
Objective: To compare the safety and efficacy of sequential intravenous (IV) to oral (PO) moxifloxacin treatment against a standard antimicrobial regimen of IV... 
SURGERY | CLINDAMYCIN | CIPROFLOXACIN PLUS METRONIDAZOLE | PENETRATION | IMIPENEM-CILASTATIN | PERFORATED APPENDICITIS | Fluoroquinolones | Intestinal Perforation - complications | Appendicitis - complications | Injections, Intravenous | Prospective Studies | Aza Compounds - therapeutic use | Humans | Middle Aged | Abdominal Abscess - drug therapy | Stomach Rupture - complications | Male | Quinolines - administration & dosage | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Safety | Penicillanic Acid - analogs & derivatives | Aza Compounds - administration & dosage | Double-Blind Method | Administration, Oral | Bacterial Infections - drug therapy | Gram-Negative Bacterial Infections - drug therapy | Treatment Outcome | Cross Infection - drug therapy | Abdominal Abscess - microbiology | Quinolines - therapeutic use | Gram-Positive Bacterial Infections - drug therapy | Anti-Bacterial Agents - administration & dosage | Piperacillin - therapeutic use | Randomized, Controlled Trials
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
by Rodríguez-Baño, Jesús and Navarro, María Dolores and Retamar, Pilar and Picón, Encarnación and Pascual, Álvaro and Estudio Infeccion Hosp Grp and Extended-Spectrum Beta-Lactamases–Red Española de Investigación en Patología Infecciosa/Grupo de Estudio de Infección Hospitalaria Group
Clinical Infectious Diseases, ISSN 1058-4838, 2012, Volume 54, Issue 2, pp. 167 - 174
In a post hoc analysis of prospective cohorts, carbapenems were not superior to in vitro active β-lactam/β-lactam inhibitor combinations... 
INFECTIOUS DISEASES | RISK-FACTORS | PIPERACILLIN-TAZOBACTAM | SUSCEPTIBILITY | MICROBIOLOGY | CLINICAL-FEATURES | IMMUNOLOGY | ANTIBIOTIC-THERAPY | RESISTANCE | STRAIN | BLOOD-STREAM INFECTIONS | KLEBSIELLA-PNEUMONIAE | ENTEROBACTERIACEAE | Multivariate Analysis | beta-Lactam Resistance | Prospective Studies | Escherichia coli - drug effects | Humans | Middle Aged | Male | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Aged, 80 and over | Penicillanic Acid - therapeutic use | Female | beta-Lactamase Inhibitors | Penicillanic Acid - analogs & derivatives | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Bacteremia - drug therapy | Proportional Hazards Models | Escherichia coli Infections - microbiology | Escherichia coli Infections - epidemiology | Escherichia coli - isolation & purification | Spain - epidemiology | Bacteremia - epidemiology | Aged | Piperacillin - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effectiveness of Amoxicillin/Clavulanate Potassium in the Treatment of Acute Bacterial Sinusitis in Children
by Wald, Ellen R and Nash, David and Eickhoff, Jens
Pediatrics, ISSN 0031-4005, 07/2009, Volume 124, Issue 1, pp. 9 - 15
OBJECTIVE: The role of antibiotic therapy in managing acute bacterial sinusitis (ABS) in children is controversial. The purpose of this study was to determine... 
Amoxicillin/clavulanate potassium | Antimicrobial agents | Treatment | Bacterial sinusitis | Images | treatment | images | antimicrobial agents | ACUTE OTITIS-MEDIA | amoxicillin/clavulanate potassium | PEDIATRICS | bacterial sinusitis | PLACEBO-CONTROLLED TRIAL | CLINICAL SINUSITIS | Acute Disease | Double-Blind Method | Sinusitis - diagnosis | Humans | Child, Preschool | Infant | Male | Treatment Outcome | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Female | Anti-Bacterial Agents - administration & dosage | Child | Sinusitis - drug therapy | Usage | Patient outcomes | Amoxicillin | Children | Drug therapy | Health aspects | Clavulanate | Sinusitis | Diseases | Studies | Pediatrics | Sinuses | Antibiotics | Childrens health | Clinical trials | Potassium
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis
by Suresh Solapure and Neela Dinesh and Radha Shandil and Vasanthi Ramachandran and Sreevalli Sharma and Deepa Bhattacharjee and Samit Ganguly and Jitendar Reddy and Vijaykamal Ahuja and Vijender Panduga and Manish Parab and K. G. Vishwas and Naveen Kumar and Meenakshi Balganesh and V. Balasubramanian
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2013, Volume 57, Issue 6, pp. 2506 - 2510
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
MEROPENEM-CLAVULANATE | CARBAPENEMS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MOXIFLOXACIN | INFECTION MODEL | DRUG-RESISTANT TUBERCULOSIS | DISCOVERY | Tuberculosis, Pulmonary - microbiology | beta-Lactams - pharmacokinetics | Clavulanic Acid - administration & dosage | Humans | Thienamycins - pharmacokinetics | Tuberculosis, Pulmonary - drug therapy | Mycobacterium tuberculosis - drug effects | Amoxicillin-Potassium Clavulanate Combination - pharmacology | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Microbial Sensitivity Tests - standards | Female | Drug Therapy, Combination | Disease Models, Animal | Thienamycins - therapeutic use | Thienamycins - administration & dosage | Clavulanic Acid - pharmacology | Streptomycin - pharmacology | Treatment Outcome | Clavulanic Acid - pharmacokinetics | Thienamycins - pharmacology | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Clavulanic Acid - therapeutic use | beta-Lactams - pharmacology | Animals | Amoxicillin-Potassium Clavulanate Combination - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | Mice | Mice, Inbred BALB C | beta-Lactams - therapeutic use | Anti-Bacterial Agents - administration & dosage | beta-Lactams - administration & dosage | Mycobacterium tuberculosis - growth & development | Experimental Therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam
by Birgy, André and Delecourt, Marine and Geslain, Guillaume and Desselas, Emilie and Caseris, Marion and Magnan, Mélanie and Mariani-Kurkdjian, Patricia and Bidet, Philippe and Bonacorsi, Stéphane
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 07/2017, Volume 72, Issue 7, pp. 1911 - 1914
Objectives: Mecillinam is recommended in France as a first-line treatment for lower urinary tract infections, due to the large increase in resistance of... 
INFECTIOUS DISEASES | URINARY-TRACT-INFECTIONS | IN-VITRO | PIVMECILLINAM | PYELONEPHRITIS | RESISTANCE | BETA-LACTAM ANTIBIOTICS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | ENTEROBACTERIACEAE | CHILDREN | Escherichia coli - drug effects | Humans | Amdinocillin - administration & dosage | beta-Lactamases - biosynthesis | Penicillinase - genetics | Amoxicillin-Potassium Clavulanate Combination - pharmacology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Amdinocillin - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | beta-Lactamases - genetics | Amdinocillin - pharmacology | Urinary Tract Infections - microbiology | Drug Therapy, Combination | France | Escherichia coli Infections - drug therapy | Genome, Bacterial | Escherichia coli - enzymology | Escherichia coli Infections - microbiology | Sequence Analysis, DNA | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Urinary Tract Infections - drug therapy | Escherichia coli - genetics | Polymorphism, Single Nucleotide | Anti-Bacterial Agents - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Amoxicillin-Clavulanate vs Ciprofloxacin for the Treatment of Uncomplicated Cystitis in Women: A Randomized Trial
by Hooton, Thomas M and Scholes, Delia and Gupta, Kalpana and Stapleton, Ann E and Roberts, Pacita L and Stamm, Walter E
JAMA, ISSN 0098-7484, 02/2005, Volume 293, Issue 8, pp. 949 - 955
CONTEXT The high prevalence of resistance to trimethoprim-sulfamethoxazole and other antimicrobials among Escherichia coli causing acute cystitis in women has... 
ACUTE BACTERIAL | UROPATHOGENIC ESCHERICHIA-COLI | HOST DEFENSES | MEDICINE, GENERAL & INTERNAL | AUGMENTIN | ACID | URINARY-TRACT INFECTIONS | AMOXICLAV | CEFACLOR | Single-Blind Method | Ciprofloxacin - therapeutic use | Humans | Cystitis - microbiology | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Cystitis - drug therapy | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Ciprofloxacin - administration & dosage | Adult | Female | Vagina - microbiology | Escherichia coli - growth & development | Anti-Bacterial Agents - administration & dosage | Comparative studies | Infections | Antibiotics | Drug therapy | Effectiveness studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Treatment of Acute Otitis Media in Children under 2 Years of Age
by Hoberman, Alejandro and Paradise, Jack L and Rockette, Howard E and Shaikh, Nader and Wald, Ellen R and Kearney, Diana H and Colborn, D. Kathleen and Kurs-Lasky, Marcia and Bhatnagar, Sonika and Haralam, Mary Ann and Zoffel, Lisa M and Jenkins, Carly and Pope, Marcia A and Balentine, Tracy L and Barbadora, Karen A
The New England Journal of Medicine, ISSN 0028-4793, 01/2011, Volume 364, Issue 2, pp. 105 - 115
In this trial involving children with carefully diagnosed acute otitis media, treatment with amoxicillin–clavulanate for 10 days had a modest but measurable... 
TRIALS | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | YOUNG-CHILDREN | INFANTS | Recurrence | Acute Disease | Otoscopy | Prognosis | Humans | Infant | Male | Otitis Media - drug therapy | Diarrhea - chemically induced | Anti-Bacterial Agents - therapeutic use | Regression Analysis | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Streptococcus pneumoniae - isolation & purification | Otitis Media - diagnosis | Treatment Failure | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Female | Anti-Bacterial Agents - adverse effects | Nasopharynx - microbiology | Evaluation | Care and treatment | Demographic aspects | Amoxicillin | Otitis media | Children | Drug therapy | Health aspects | Diseases | Ear diseases | Pediatrics | Pneumonia | Statistical analysis | Illnesses | Medical disorders
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate
by Lipsky, Benjamin A and Giordano, Philip and Choudhri, Shurjeel and Song, James
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 8/2007, Volume 60, Issue 2, pp. 370 - 376
Objectives Complicated skin and skin structure infections (cSSSIs), including diabetic foot infections (DFIs), are often polymicrobial, requiring combination... 
Fluoroquinolones | β-lactam inhibitors | Penicillins | Complicated skin and skin structure infections | SOFT-TISSUE INFECTIONS | INFECTIOUS DISEASES | ANTIMICROBIAL AGENTS | MICROBIOLOGY | complicated skin and skin structure infections | COMPLICATED SKIN | MULTICENTER TRIAL | SKIN-STRUCTURE INFECTIONS | beta-lactam inhibitors | ANAEROBIC-BACTERIA | PHARMACOLOGY & PHARMACY | OPEN-LABEL TRIAL | AMOXICILLIN-CLAVULANATE | fluoroquinolones | penicillins | IN-VITRO ACTIVITY | Aza Compounds - therapeutic use | Humans | Aza Compounds - adverse effects | Male | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Penicillanic Acid - therapeutic use | Female | Anti-Bacterial Agents - adverse effects | Penicillanic Acid - adverse effects | Bacterial Infections - microbiology | Penicillanic Acid - analogs & derivatives | Databases, Factual | Double-Blind Method | Bacterial Infections - drug therapy | Diabetic Foot - drug therapy | Diabetic Foot - surgery | Bacterial Infections - surgery | Diabetic Foot - microbiology | Piperacillin - adverse effects | Aged | Quinolines - therapeutic use | Quinolines - adverse effects | Piperacillin - therapeutic use | Skin diseases | Chemotherapy | Infections | Diabetes | Microbiology | Feet
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text β-Lactams against Tuberculosis — New Trick for an Old Dog?
by Sevene, Esperança and Diacon, Andreas H and Ballell, Lluís and van der Merwe, Lize and Lange, Christoph and García-Basteiro, Alberto L and Barnard, Marinus and Barros-Aguirre, David and von Groote-Bidlingmaier, Florian
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 4, pp. 393 - 394
To the Editor: New treatments are needed to combat the worldwide increase in resistance to antituberculosis drugs. 1 The outlook for patients with tuberculosis... 
MEDICINE, GENERAL & INTERNAL | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Mycobacterium tuberculosis | Humans | beta-Lactamase Inhibitors - therapeutic use | Colony Count, Microbial | beta-Lactams - therapeutic use | Drug Discovery | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Fluoroquinolones | Chemotherapy | Tuberculosis | Acids | Antiretroviral agents | Clinical trials | Drug resistance | Patients | Isoniazid | Rifampin | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Antibiotics for prolonged wet cough in children
by Marchant, Julie M and Petsky, Helen L and Morris, Peter S and Chang, Anne B
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 07/2018, Volume 2018, Issue 7, p. CD004822
Background Cough is a frequent symptom presenting to doctors. The most common cause of childhood chronic (greater than fours weeks' duration) wet cough is... 
INFECTIONS | MANAGEMENT | Humans | RANDOMIZED CONTROLLED-TRIAL | NATURAL-HISTORY | SUPPURATIVE LUNG-DISEASE | Anti-Bacterial Agents [therapeutic use] | Randomized Controlled Trials as Topic | PROTRACTED BACTERIAL BRONCHITIS | MEDICINE, GENERAL & INTERNAL | Cough [classification; drug therapy] | Sputum [secretion] | DOUBLE-BLIND | AMOXICILLIN-CLAVULANATE | Chronic Disease | Child | YOUNG-CHILDREN | CHEST GUIDELINE | Cough - drug therapy | Child, Preschool | Infant | Erythromycin - therapeutic use | Disease Progression | Sputum - metabolism | Anti-Bacterial Agents - therapeutic use | Erythromycin - adverse effects | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Intention to Treat Analysis | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Anti-Bacterial Agents - adverse effects | Cough - classification
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text A Placebo-Controlled Trial of Antimicrobial Treatment for Acute Otitis Media
by Tähtinen, Paula A and Laine, Miia K and Huovinen, Pentti and Jalava, Jari and Ruuskanen, Olli and Ruohola, Aino
The New England Journal of Medicine, ISSN 0028-4793, 01/2011, Volume 364, Issue 2, pp. 116 - 126
In this study of stringently defined acute otitis media in children in Finland, amoxicillin–clavulanate was shown to significantly reduce the rate of treatment... 
DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | THERAPY | CLINICAL-TRIALS | DOUBLE-BLIND | MYRINGOTOMY | MICROBIOLOGY | ANTIBIOTIC-TREATMENT | AMOXICILLIN | CHILDREN | Acute Disease | Double-Blind Method | Humans | Kaplan-Meier Estimate | Child, Preschool | Infant | Male | Treatment Outcome | Otitis Media - drug therapy | Diarrhea - chemically induced | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Eczema - chemically induced | Otitis Media - diagnosis | Intention to Treat Analysis | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Female | Anti-Bacterial Agents - adverse effects | Complications and side effects | Usage | Care and treatment | Patient outcomes | Amoxicillin | Anti-infective agents | Otitis media | Children | Drug therapy | Diseases | Ear diseases | Antimicrobial agents | Bacterial infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Effectiveness of Patient Choice in Nonoperative vs Surgical Management of Pediatric Uncomplicated Acute Appendicitis
by Minneci, Peter C and Mahida, Justin B and Lodwick, Daniel L and Sulkowski, Jason P and Nacion, Kristine M and Cooper, Jennifer N and Ambeba, Erica J and Moss, R. Lawrence and Deans, Katherine J
JAMA Surgery, ISSN 2168-6254, 05/2016, Volume 151, Issue 5, pp. 408 - 415
IMPORTANCE: Current evidence suggests that nonoperative management of uncomplicated appendicitis is safe, but overall effectiveness is determined by combining... 
SURGERY | RANDOMIZED-CONTROLLED-TRIAL | GENERIC CORE SCALES | DECISION-MAKING | CLINICAL-TRIAL | COMPLICATED APPENDICITIS | LAPAROSCOPIC APPENDECTOMY | CLAVULANIC-ACID | OPEN APPENDECTOMY | ANTIBIOTIC-THERAPY | CHILDREN | Appendicitis - complications | Appendectomy | Prospective Studies | Humans | Patient Participation | Male | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Appendicitis - economics | Metronidazole - therapeutic use | Penicillanic Acid - therapeutic use | Female | Child | Penicillanic Acid - analogs & derivatives | Appendicitis - drug therapy | Ciprofloxacin - therapeutic use | Treatment Outcome | Laparoscopy | Patient Preference | Health Care Costs | Adolescent | Appendicitis - surgery | Family | Anti-Bacterial Agents - administration & dosage | Piperacillin - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights